Survival Analysis on TCGA UCEC (test)
0.791C-IndexCox-MT
Evaluation results
| Method | Links | ||
|---|---|---|---|
| Cox-MTModality=Single-modal, Input Type=Gene Expression2026.01 | 0.791 | — | |
| PathMoGSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.68 | 71.4 | |
| Uni-modalModality=WSI2023.11 | 0.63 | — | |
| HEALNetFusion strategy=Hybrid early-fusion2023.11 | 0.626 | — | |
| PerceiverFusion strategy=Early Fusion2023.11 | 0.623 | — | |
| MultiModNFusion strategy=Sequential Fusion2023.11 | 0.61 | — | |
| Cox-nnetModality=Single-modal, Input Type=Gene Expression2026.01 | 0.608 | — | |
| PCLSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.6 | 62.3 | |
| FGCNSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.598 | 60.2 | |
| CAMRSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.592 | 62.4 | |
| PorpoiseFusion strategy=Late2023.11 | 0.59 | — | |
| MCATFusion strategy=Intermediate2023.11 | 0.589 | — | |
| MOTCATFusion strategy=Intermediate2023.11 | 0.587 | — | |
| HFBSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.582 | 53.2 | |
| PathGSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.568 | 58.5 | |
| Uni-modalModality=Omics2023.11 | 0.55 | — | |
| RSFSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.519 | 54.8 | |
| CoxSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.503 | 53.1 | |
| GraphSSample Size (N)=541, Evaluation Protocol=5-fold cross-validation2026.04 | 0.503 | 60.2 |